The Use of Acute Immunosuppressive Therapy to Improve Antibiotic Efficacy against Intracellular Staphylococcus aureus.
The Use of Acute Immunosuppressive Therapy to Improve Antibiotic Efficacy against Intracellular Staphylococcus aureus.
复制标题
DOI:
10.1128/spectrum.00858-22
复制
发表时间:
2022-06-29
影响因子:
3.7
通讯作者:
Conlon, Brian P.
中科院分区:
文献类型:
--
作者:
Beam, Jenna E.;Maiocchi, Sophie;Cartaya, Ana;Rowe, Sarah E.;Bahnson, Edward S. M.;Conlon, Brian P.
Interactions between Staphylococcus aureus and the host immune system can have significant impacts on antibiotic efficacy, suggesting that targeting and modulating the immune response to S. aureus infection may improve antibiotic efficacy and improve infection outcome. As we’ve previously shown, high levels of reactive oxygen species (ROS), associated with an M1-like proinflammatory macrophage response, potently induce antibiotic tolerance in S. aureus. Although the proinflammatory immune response is critical for initial control of pathogen burden, recent studies demonstrate that modulation of the macrophage response to an anti-inflammatory, or M2-like, response facilitates resolution of established S. aureus skin and soft tissue infections, arthritis, and bacteremia. Here, we evaluated the impact of host-directed immunosuppressive chemotherapeutics and anti-inflammatory agents on antibiotic efficacy against S. aureus. IMPORTANCE Staphylococcus aureus is the leading cause of hospital-acquired infections in the United States with high rates of antibiotic treatment failure. Macrophages represent an important intracellular niche in experimental models of S. aureus bacteremia. Although a proinflammatory macrophage response is critical for controlling infection, previous studies have identified an antagonistic relationship between antibiotic treatment and the proinflammatory macrophage response. Reactive oxygen species, produced by macrophages during respiratory burst, coerce S. aureus into an antibiotic tolerant state, leading to poor treatment outcome. Here, we aimed to determine the potential of host-directed immunomodulators that reduce the production of reactive oxygen species to improve antibiotic efficacy against intracellular S. aureus.
登录
查看更多内容
影响因子:
4.6
作者:
Xia H;Chen L;Liu H;Sun Z;Yang W;Yang Y;Cui S;Li S;Wang Y;Song L;Abdelgawad AF;Shang Y;Yao S
通讯作者:
Yao S
影响因子:
30.3
作者:
Hill, Peter W. S.;Moldoveanu, Ana Laura;Helaine, Sophie
通讯作者:
Helaine, Sophie
影响因子:
39.3
作者:
Liu T;Zhang L;Joo D;Sun SC
通讯作者:
Sun SC
影响因子:
4.6
作者:
Haim YO;Unger ND;Souroujon MC;Mittelman M;Neumann D
通讯作者:
Neumann D
影响因子:
3.7
作者:
Ali, Malika;Bonay, Marcel;Deramaudt, Therese B.
通讯作者:
Deramaudt, Therese B.